Cardiff Oncology (CRDF) Assets Average (2016 - 2025)
Cardiff Oncology (CRDF) has disclosed Assets Average for 14 consecutive years, with $62.8 million as the latest value for Q4 2025.
- Quarterly Assets Average fell 21.5% to $62.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $62.8 million through Dec 2025, down 21.5% year-over-year, with the annual reading at $79.5 million for FY2025, 11.05% down from the prior year.
- Assets Average hit $62.8 million in Q4 2025 for Cardiff Oncology, down from $69.8 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $145.4 million in Q4 2021 to a low of $62.8 million in Q4 2025.
- Historically, Assets Average has averaged $103.6 million across 5 years, with a median of $97.5 million in 2023.
- Biggest five-year swings in Assets Average: skyrocketed 961.36% in 2021 and later crashed 31.33% in 2024.
- Year by year, Assets Average stood at $145.4 million in 2021, then fell by 17.55% to $119.9 million in 2022, then dropped by 29.08% to $85.0 million in 2023, then fell by 5.88% to $80.0 million in 2024, then decreased by 21.5% to $62.8 million in 2025.
- Business Quant data shows Assets Average for CRDF at $62.8 million in Q4 2025, $69.8 million in Q3 2025, and $80.3 million in Q2 2025.